PET/MRI: A Promising Tool for Detecting Cardiac Neuroendocrine Tumor Metastasis
1. Abstract Neuroendocrine Tumors (NET) staging, including metastasis detec- tion, will affect the management and the prognosis of the disease. MRI imaging and somatostatin receptor [SSTR]-targeted PET ap- pear complementary for metastasis detection with a higher sensitivity of PET for lymph node and lung metastases identification and a higher sensitivity of MRI for liver metastases …
PET/MRI: A Promising Tool for Detecting Cardiac Neuroendocrine Tumor Metastasis Read More »